Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Pro Medicus Limited (PMCUF) vs. Competitors

39 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
PMCUFPro Medicus Limited$131.10$13.49B76.30-21.24%Strong BuyUnlock the PMCUF analyst price target with TipRanks PremiumPMCUFUnlock the PMCUF top-analyst price target with TipRanks Premium
AU:M7TMach7 TechnologiesAUD 0.26AUD 61.10M-6.84-17.46%Moderate BuyUnlock the AU:M7T analyst price target with TipRanks PremiumPMCUF vs AU:M7TUnlock the AU:M7T top-analyst price target with TipRanks Premium
AU:BMTBeamtree Holdings LtdAUD 0.07AUD 20.08M-1.08-66.00%Moderate BuyUnlock the AU:BMT analyst price target with TipRanks PremiumPMCUF vs AU:BMTUnlock the AU:BMT top-analyst price target with TipRanks Premium
AU:SHGSingular Health Group LtdAUD 0.18AUD 61.96M-8.62-32.08%Moderate BuyUnlock the AU:SHG analyst price target with TipRanks PremiumPMCUF vs AU:SHGUnlock the AU:SHG top-analyst price target with TipRanks Premium
AU:AYAArtrya LimitedAUD 2.70AUD 443.94M-14.77-14.56%Strong BuyUnlock the AU:AYA analyst price target with TipRanks PremiumPMCUF vs AU:AYAUnlock the AU:AYA top-analyst price target with TipRanks Premium
AU:ALCAlcidion Group LimitedAUD 1.20AUD 168.73M71.188.64%Strong BuyUnlock the AU:ALC analyst price target with TipRanks PremiumPMCUF vs AU:ALCUnlock the AU:ALC top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
PMCUFPro Medicus Limited131.10-29.84-18.54%
AU:M7TMach7 Technologies0.26-0.09-25.71%
AU:BMTBeamtree Holdings Ltd0.07-0.13-66.00%
AU:SHGSingular Health Group Ltd0.18-0.10-34.55%
AU:AYAArtrya Limited2.70-0.47-14.83%
AU:ALCAlcidion Group Limited1.200.2019.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts